世界の膀胱がん治療薬市場:販売動向2019

QYResearchが発行した調査報告書(DATA907A1538)
◆英語タイトル:Global Bladder Cancer Treatment Drugs Sales Market Report 2019
◆商品コード:DATA907A1538
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年8月(※2024年版があります。お問い合わせください。)
◆ページ数:108
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、膀胱がん治療薬の世界市場について調査・分析し、膀胱がん治療薬のメーカー別販売量、市場シェア分析、種類別販売分析(非筋浸潤性膀胱がん、筋浸潤性膀胱がん)、用途別販売分析(Low-Grade Tumors、High-Grade Tumors)、地域別販売分析(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・膀胱がん治療薬市場概要
・膀胱がん治療薬のメーカー別販売量・メーカー別シェア
・膀胱がん治療薬の種類別販売量(非筋浸潤性膀胱がん、筋浸潤性膀胱がん)
・膀胱がん治療薬の用途別販売量(Low-Grade Tumors、High-Grade Tumors)
・膀胱がん治療薬の地域別販売量・市場シェア
・膀胱がん治療薬のアメリカ市場規模(2014年-2019年)
・膀胱がん治療薬のヨーロッパ市場規模(2014年-2019年)
・膀胱がん治療薬の中国市場規模(2014年-2019年)
・膀胱がん治療薬の日本市場規模(2014年-2019年)
・膀胱がん治療薬の東南アジア市場規模(2014年-2019年)
・膀胱がん治療薬のインド市場規模(2014年-2019年)
・膀胱がん治療薬メーカー分析(企業概要、製品概要、販売量、売上、価格等)
・膀胱がん治療薬のコスト分析
・膀胱がん治療薬販売チャネル、流通業者、顧客
・膀胱がん治療薬の世界市場動向・機会・成長要因・課題
・膀胱がん治療薬の種類別世界市場予測(非筋浸潤性膀胱がん、筋浸潤性膀胱がん)
・膀胱がん治療薬の用途別世界市場予測(Low-Grade Tumors、High-Grade Tumors)
・膀胱がん治療薬のアメリカ市場予測(2019年-2025年)
・膀胱がん治療薬のヨーロッパ市場予測(2019年-2025年)
・膀胱がん治療薬の中国市場予測(2019年-2025年)
・膀胱がん治療薬の日本市場予測(2019年-2025年)
・膀胱がん治療薬の東南アジア市場予測(2019年-2025年)
・膀胱がん治療薬のインド市場予測(2019年-2025年)
...
【レポートの概要】

Bladder cancer refers to the growth of abnormal tissues in the lining of the bladder. These abnormal tissues are referred to as tumor, which even spread in the surrounding tissues or muscles. The increase in prevalence of bladder cancer, advanced health care services, technological advancements, drug innovations with regard to the treatment of this cancer for ex launch of EOquin, and government initiatives could contribute to the growth of the bladder cancer treatment drugs market. Majority of bladder cancer patients are over the age of 60. Rise in the geriatric population is anticipated to drive the market growth. Additionally, growing awareness about bladder diseases, therapies available in the market, and increasing health care expenditure are significantly contributing toward the growth of the global bladder cancer treatment drugs market. However, rise in number of patent expirations, increase in use of generic drugs, and asymptomatic nature of the disease are some major factors that could hamper the growth of the market.
North America dominates the bladder cancer treatment drugs market followed by Europe. Rise in bladder cancer cases, availability of advanced health care solutions, developed health care infrastructure, and growing concern regarding the disease in these regions are key factors attributed to the significant market share. However, rapidly increasing prevalence of bladder cancer in the Asia Pacific region, in which India being the major country having large number of patients suffering from this disease, is expected to experience a high growth rate in the bladder cancer treatment drugs market over the forecast period. Further, increasing awareness about cancer diagnosis, growing demand for improved bladder cancer treatments and therapies, developing health care infrastructure, and rising health care expenditure in the region can drive the market growth. 

The global Bladder Cancer Treatment Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report studies the global Bladder Cancer Treatment Drugs market status and forecast, categorizes the global Bladder Cancer Treatment Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Pfizer
GlaxoSmithKline
Celgene Corporation
Sanofi
Hoffmann-La Roche
Novartis International
Eli Lilly
AstraZeneca
Bristol-Myers Squibb

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Non-Muscle-Invasive Bladder Cancer
Muscle-Invasive Bladder Cancer

Segment by Application
Low-Grade Tumors
High-Grade Tumors

【レポートの目次】

Table of Contents

Global Bladder Cancer Treatment Drugs Sales Market Report 2019
1 Bladder Cancer Treatment Drugs Market Overview
1.1 Bladder Cancer Treatment DrugsProduct Overview
1.2 Bladder Cancer Treatment Drugs Segment by Type
1.2.1 Global Bladder Cancer Treatment Drugs Sales Comparison by Types (2014-2025)
1.2.2 Non-Muscle-Invasive Bladder Cancer
1.2.3 Muscle-Invasive Bladder Cancer
1.3 Bladder Cancer Treatment Drugs Segment by Application
1.3.1 Global Bladder Cancer Treatment Drugs Sales Comparison by Application (2014-2025)
1.3.1 Low-Grade Tumors
1.3.2 High-Grade Tumors
1.4 Bladder Cancer Treatment Drugs Market by Region
1.4.1 Global Bladder Cancer Treatment Drugs Revenue Comparison by Region (2014-2025)
1.4.2 United States Bladder Cancer Treatment Drugs Status and Prospect (2014-2025)
1.4.3 Europe Bladder Cancer Treatment Drugs Status and Prospect (2014-2025)
1.4.4 China Bladder Cancer Treatment Drugs Status and Prospect (2014-2025)
1.4.5 Japan Bladder Cancer Treatment Drugs Status and Prospect (2014-2025)
1.4.6 Southeast Asia Bladder Cancer Treatment Drugs Status and Prospect (2014-2025)
1.4.7 India Bladder Cancer Treatment Drugs Status and Prospect (2014-2025)
1.5 Global Bladder Cancer Treatment Drugs Sales and Revenue (2014-2025)
1.5.1 Global Bladder Cancer Treatment Drugs Sales and Growth Rate (2014-2025)
1.5.2 Global Bladder Cancer Treatment Drugs Revenue and Growth Rate (2014-2025)

2 Bladder Cancer Treatment Drugs by Company, Region, Type and Application
2.1 Global Bladder Cancer Treatment Drugs Market Competition by Companies
2.1.1 Global Bladder Cancer Treatment Drugs Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Bladder Cancer Treatment Drugs Revenue Market Share by Company (2014-2019)
2.2 Global Bladder Cancer Treatment Drugs Sales and Revenue by Region
2.2.1 Global Bladder Cancer Treatment Drugs Sales Market Share by Region (2014-2019)
2.2.2 Global Bladder Cancer Treatment Drugs Revenue Market Share by Region (2014-2019)
2.3 Global Bladder Cancer Treatment Drugs Sales and Revenue by Type
2.3.1 Global Bladder Cancer Treatment Drugs Sales Market Share by Type (2014-2019)
2.3.2 Global Bladder Cancer Treatment Drugs Revenue Market Share by Type (2014-2019)
2.4 Global Bladder Cancer Treatment Drugs Sales by Application

3 United States Bladder Cancer Treatment Drugs Sales, Revenue and Price
3.1 United States Bladder Cancer Treatment Drugs Sales and Revenue (2014-2019)
3.1.1 United States Bladder Cancer Treatment Drugs Sales Growth Rate (2014-2019)
3.1.2 United States Bladder Cancer Treatment Drugs Revenue Growth Rate (2014-2019)
3.1.3 United States Bladder Cancer Treatment Drugs Price Trend (2014-2019)
3.2 United States Bladder Cancer Treatment Drugs Sales Market Share by Company
3.3 United States Bladder Cancer Treatment Drugs Sales Market Share by Type
3.4 United States Bladder Cancer Treatment Drugs Sales Market Share by Application

4 Europe Bladder Cancer Treatment Drugs Sales, Revenue and Price
4.1 Europe Bladder Cancer Treatment Drugs Sales and Value (2014-2019)
4.1.1 Europe Bladder Cancer Treatment Drugs Sales Growth Rate (2014-2019)
4.1.2 Europe Bladder Cancer Treatment Drugs Revenue Growth Rate (2014-2019)
4.1.3 Europe Bladder Cancer Treatment Drugs Price Trend (2014-2019)
4.2 Europe Bladder Cancer Treatment Drugs Sales Market Share by Company
4.3 Europe Bladder Cancer Treatment Drugs Sales Market Share by Type
4.4 Europe Bladder Cancer Treatment Drugs Sales Market Share by Application

5 China Bladder Cancer Treatment Drugs Sales, Revenue and Price
5.1 China Bladder Cancer Treatment Drugs Sales and Revenue (2014-2019)
5.1.1 China Bladder Cancer Treatment Drugs Sales Growth Rate (2014-2019)
5.1.2 China Bladder Cancer Treatment Drugs Revenue Growth Rate (2014-2019)
5.1.3 China Bladder Cancer Treatment Drugs Price Trend (2014-2019)
5.2 China Bladder Cancer Treatment Drugs Sales Market Share by Company
5.3 China Bladder Cancer Treatment Drugs Sales Market Share by Type
5.4 China Bladder Cancer Treatment Drugs Sales Market Share by Application

6 Japan Bladder Cancer Treatment Drugs Sales, Revenue and Price
6.1 Japan Bladder Cancer Treatment Drugs Sales and Value (2014-2019)
6.1.1 Japan Bladder Cancer Treatment Drugs Sales Growth Rate (2014-2019)
6.1.2 Japan Bladder Cancer Treatment Drugs Revenue Growth Rate (2014-2019)
6.1.3 Japan Bladder Cancer Treatment Drugs Price Trend (2014-2019)
6.2 Japan Bladder Cancer Treatment Drugs Sales Market Share by Company
6.3 Japan Bladder Cancer Treatment Drugs Sales Market Share by Type
6.4 Japan Bladder Cancer Treatment Drugs Sales Market Share by Application

7 Southeast Asia Bladder Cancer Treatment Drugs Sales, Revenue and Price
7.1 Southeast Asia Bladder Cancer Treatment Drugs Sales and Value (2014-2019)
7.1.1 Southeast Asia Bladder Cancer Treatment Drugs Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Bladder Cancer Treatment Drugs Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Bladder Cancer Treatment Drugs Price Trend (2014-2019)
7.2 Southeast Asia Bladder Cancer Treatment Drugs Sales Market Share by Company
7.3 Southeast Asia Bladder Cancer Treatment Drugs Sales Market Share by Type
7.4 Southeast Asia Bladder Cancer Treatment Drugs Sales Market Share by Application

8 India Bladder Cancer Treatment Drugs Sales, Revenue and Price
8.1 India Bladder Cancer Treatment Drugs Sales and Value (2014-2019)
8.1.1 India Bladder Cancer Treatment Drugs Sales Growth Rate (2014-2019)
8.1.2 India Bladder Cancer Treatment Drugs Revenue Growth Rate (2014-2019)
8.1.3 India Bladder Cancer Treatment Drugs Price Trend (2014-2019)
8.2 India Bladder Cancer Treatment Drugs Sales Market Share by Company
8.3 India Bladder Cancer Treatment Drugs Sales Market Share by Type
8.4 India Bladder Cancer Treatment Drugs Sales Market Share by Application

9 Company Profiles and Key Figures in Bladder Cancer Treatment Drugs Business
9.1 Pfizer
9.1.1 Pfizer Bladder Cancer Treatment Drugs Production Sites and Area Served
9.1.2 Bladder Cancer Treatment Drugs Specification and Application
9.1.3 Pfizer Bladder Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Bladder Cancer Treatment Drugs Production Sites and Area Served
9.2.2 Bladder Cancer Treatment Drugs Specification and Application
9.2.3 GlaxoSmithKline Bladder Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Celgene Corporation
9.3.1 Celgene Corporation Bladder Cancer Treatment Drugs Production Sites and Area Served
9.3.2 Bladder Cancer Treatment Drugs Specification and Application
9.3.3 Celgene Corporation Bladder Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Sanofi
9.4.1 Sanofi Bladder Cancer Treatment Drugs Production Sites and Area Served
9.4.2 Bladder Cancer Treatment Drugs Specification and Application
9.4.3 Sanofi Bladder Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Hoffmann-La Roche
9.5.1 Hoffmann-La Roche Bladder Cancer Treatment Drugs Production Sites and Area Served
9.5.2 Bladder Cancer Treatment Drugs Specification and Application
9.5.3 Hoffmann-La Roche Bladder Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Novartis International
9.6.1 Novartis International Bladder Cancer Treatment Drugs Production Sites and Area Served
9.6.2 Bladder Cancer Treatment Drugs Specification and Application
9.6.3 Novartis International Bladder Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Eli Lilly
9.7.1 Eli Lilly Production Sites and Area Served
9.7.2 Bladder Cancer Treatment Drugs Specification and Application
9.7.3 Eli Lilly Bladder Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
9.8 AstraZeneca
9.8.1 AstraZeneca Bladder Cancer Treatment Drugs Production Sites and Area Served
9.8.2 Bladder Cancer Treatment Drugs Specification and Application
9.8.3 AstraZeneca Bladder Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business and Markets Served
9.9 Bristol-Myers Squibb
9.9.1 Bristol-Myers Squibb Bladder Cancer Treatment Drugs Production Sites and Area Served
9.9.2 Bladder Cancer Treatment Drugs Specification and Application
9.9.3 Bristol-Myers Squibb Bladder Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business and Markets Served

10 Bladder Cancer Treatment Drugs Maufacturing Cost Analysis
10.1 Bladder Cancer Treatment Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Bladder Cancer Treatment Drugs
10.4 Bladder Cancer Treatment Drugs Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Bladder Cancer Treatment Drugs Distributors List
11.3 Bladder Cancer Treatment Drugs Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Bladder Cancer Treatment Drugs Market Forecast
13.1 Global Bladder Cancer Treatment Drugs Sales, Revenue and Price Forecast
13.1.1 Global Bladder Cancer Treatment Drugs Sales Growth Forecast (2019-2025)
13.1.2 Global Bladder Cancer Treatment Drugs Revenue Growth Forecast (2019-2025)
13.1.3 Global Bladder Cancer Treatment Drugs Price Trend Forecast (2019-2025)
13.2 Global Bladder Cancer Treatment Drugs Forecast by Region
13.2.1 Global Bladder Cancer Treatment Drugs Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Bladder Cancer Treatment Drugs Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Bladder Cancer Treatment Drugs Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Bladder Cancer Treatment Drugs Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Bladder Cancer Treatment Drugs Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Bladder Cancer Treatment Drugs Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Bladder Cancer Treatment Drugs Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Bladder Cancer Treatment Drugs Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Bladder Cancer Treatment Drugs Forecast by Type
13.3.1 Global Bladder Cancer Treatment Drugs Sales Forecast by Type (2019-2025)
13.3.2 Global Bladder Cancer Treatment Drugs Revenue Forecast by Type (2019-2025)
13.3.3 Global Bladder Cancer Treatment Drugs Price Forecast by Type (2019-2025)
13.4 Global Bladder Cancer Treatment Drugs Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の膀胱がん治療薬市場:販売動向2019(Global Bladder Cancer Treatment Drugs Sales Market Report 2019)]についてメールでお問い合わせはこちらでお願いします。